Tevogen Bio Holdings Inc. (TVGN)
NASDAQ: TVGN · Real-Time Price · USD
6.50
+0.01 (0.15%)
Apr 29, 2026, 9:43 AM EDT - Market open
Tevogen Bio Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -26.28 | -13.73 | -60.48 | -22.04 | -15.6 |
| Depreciation & Amortization | 0.51 | 0.4 | 0.38 | 0.23 | 0.01 |
| Other Amortization | - | 0.8 | - | - | - |
| Stock-Based Compensation | 16.22 | 40.76 | - | 4.58 | 0.58 |
| Other Operating Activities | -0.06 | -40.23 | 51.64 | 8.32 | 10.98 |
| Change in Accounts Payable | -1.96 | 1.69 | 1.11 | 0.35 | -1.09 |
| Change in Other Net Operating Assets | -0.76 | -1.69 | -0.82 | -0.1 | -0.16 |
| Operating Cash Flow | -12.33 | -12 | -8.17 | -8.66 | -5.27 |
| Capital Expenditures | -0.06 | - | -0.13 | -0.48 | -0.11 |
| Investing Cash Flow | -0.06 | - | -0.13 | -0.48 | -0.11 |
| Long-Term Debt Issued | 3.4 | 1 | 4 | 7.5 | 12.5 |
| Net Debt Issued (Repaid) | 3.4 | 1 | 4 | 7.5 | 12.5 |
| Issuance of Common Stock | 8.36 | - | - | - | - |
| Other Financing Activities | -0.1 | 0.23 | -0.13 | - | - |
| Financing Cash Flow | 11.66 | 12.23 | 3.87 | 7.5 | 12.5 |
| Net Cash Flow | -0.73 | 0.23 | -4.43 | -1.63 | 7.12 |
| Free Cash Flow | -12.39 | -12 | -8.3 | -9.13 | -5.38 |
| Free Cash Flow Per Share | -3.73 | -4.09 | -16.77 | -18.09 | -10.73 |
| Levered Free Cash Flow | -1.77 | 10.62 | -3.52 | -4.11 | - |
| Unlevered Free Cash Flow | -1.65 | 10.73 | -2.77 | -3.53 | - |
| Change in Working Capital | -2.72 | -0.01 | 0.29 | 0.26 | -1.25 |
Source: S&P Capital IQ. Standard template.
Financial Sources.